BioPharm International
October 01, 2017
Features
30
10
Manufacturers introduce innovations in glass and plastic packaging for injectables.
October 01, 2017
From the Editor
30
10
Reeling from financial and tropical storms, Puerto Rico needs stable industry to aid its recovery.
October 01, 2017
Features
30
10
Detecting viral contaminants in biologic-based medicines-and identifying their source-requires a holistic testing approach.
October 01, 2017
Cover Story
30
10
There is a lot of interest in delivering biologics via non-invasive routes in attempt to improve patient compliance and convenience.
October 01, 2017
Regulatory Beat
30
10
Industry and FDA face new fee structures and new challenges in implementing fee initiatives.
October 01, 2017
Perspectives on Outsourcing
30
10
Mergers and acquisitions are positive for the CDMO industry, but there is a downside.
October 01, 2017
Ask the Expert
30
10
Focusing on whether the product meets its defined quality attributes should help one make reasonable, documentable, and defendable risk-based decisions, according to Susan Schniepp, distinguished fellow at Regulatory Compliance Associates.
October 01, 2017
Manufacturing
30
10
Process analytical testing for biopharmaceuticals requires enhanced methods due to complex bioprocesses.
October 01, 2017
Features
30
10
A UHPLC SEC approach for protein aggregate analysis of mAbs is presented.
October 01, 2017
Downstream Processing
30
10
This study outlines methods for an alternative protein-polishing process for challenging proteins.
October 01, 2017
Peer-Reviewed Research
30
10
. This study is an attempt to produce a fusion protein by binding the fragment NT-gp96 in upstream of sequence of the N terminal fragment (NT300) of the NS5B gene in an expression vector.
October 01, 2017
Issue PDF
30
10
Click the title above to open the BioPharm International October 2017 issue in an interactive PDF format.